Drug Screening Kits-OCME-FY11-Goods-RFQ

The District of Columbia Office of Contracting and Procurement is initiating a procurement process to establish a Blanket Purchase Agreement (BPA) for toxicology kits on behalf of the D.C. Office of the Chief Medical Examiner (OCME). This solicitation, identified by contract number 66c85f92829eb5d8690760bc, is seeking a qualified vendor to provide drug screening kits on an as-needed basis. The procurement is specifically for goods, with a focused requirement for toxicology testing materials that will support the medical examiner's operational needs. The solicitation was posted on October 5, 2010, with a relatively short response window, requiring interested vendors to submit their proposals by October 11, 2010. While specific evaluation criteria are not detailed in the provided documentation, the procurement appears to be structured as a standard competitive request for quotation (RFQ) process, likely assessing vendor capabilities, pricing, product specifications, and delivery capacity.

No explicit set-aside designations or specific restrictions for disadvantaged enterprises were mentioned in the contract opportunity description. The procurement seems open to standard commercial vendors capable of supplying toxicology screening kits. Without additional context, the potential award value and budget range are not specified in the provided information. The Blanket Purchase Agreement structure suggests the contract will enable flexible, as-needed purchasing of drug screening kits for the OCME, potentially allowing multiple task or delivery orders under a single overarching agreement. The short timeline between posting and submission dates indicates an urgent or time-sensitive procurement need for these medical testing supplies. While incumbent vendors are not identified, the solicitation implies a strategic procurement approach to ensure consistent access to necessary toxicology testing materials for the District of Columbia's medical examiner operations.